• FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: None
    PBS, pH 7.2
  • Concentration information loading...
  • PurityProtein G purified
  • ClonalityMonoclonal
  • IsotypeIgG2a
  • Light chain typekappa
  • Research areas


Our Abpromise guarantee covers the use of ab56481 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesWB: Use at a concentration of 1-5 µg/ml.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionProbable acetyl-CoA transporter necessary for O-acetylation of gangliosides.
    • Tissue specificityUbiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. With strongest signals in pancreas.
    • Involvement in diseaseSpastic paraplegia autosomal dominant 42 (SPG42) [MIM:612539]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. Note=The disease is caused by mutations affecting the gene represented in this entry.
      Congenital cataracts, hearing loss, and neurodegeneration (CCHLND) [MIM:614482]: An autosomal recessive disorder characterized by congenital cataracts, severe psychomotor retardation, and hearing loss associated with decreased serum ceruloplasmin and copper. Brain MRI shows cerebral and cerebellar atrophy and hypomyelination. Note=The disease is caused by mutations affecting the gene represented in this entry.
    • Sequence similaritiesBelongs to the SLC33A transporter family.
    • Cellular localizationEndoplasmic reticulum membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • ACATN antibody
      • ACATN_HUMAN antibody
      • Acetyl CoA transporter antibody
      • Acetyl Coenzyme A transporter antibody
      • Acetyl coenzyme A transporter 1 antibody
      • Acetyl-CoA transporter 1 antibody
      • Acetyl-coenzyme A transporter 1 antibody
      • AT 1 antibody
      • AT-1 antibody
      • AT1 antibody
      • Human Angiotensin II Type 1 Receptor antibody
      • Slc33a1 antibody
      • Solute carrier family 33 (acetyl CoA transporter) member 1 antibody
      • Solute carrier family 33 member 1 antibody
      • spastic paraplegia 42 (autosomal dominant) antibody
      • SPG42 antibody
      see all

    Anti-SLC33A1 antibody images

    • Predicted band size : 61 kDa
      SLC33A1 antibody (ab56481) at 1ug/lane + PC-12 cell lysate at 25ug/lane.

    References for Anti-SLC33A1 antibody (ab56481)

    ab56481 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab56481.
    Please use the links above to contact us or submit feedback about this product.